Healthcare Industry News: ultrasound
News Release - November 9, 2011
Cerebral Stethoscope Offers New Tool for Early Detection of AneurysmsALPINE, N.J., Nov. 9, 2011 -- (Healthcare Sales & Marketing Network) -- ProTron Technologies announces a new approach to early detection of aneurysms in vascular systems through the patented Stethotron® Cerebral Stethoscope.
In the USA alone, six million people have a brain aneurysm. In 50% of ruptured aneurysms, patients in the age group of 35-60 die within minutes.
One of the major factors leading to aneurysm is vascular atherosclerosis. Without invasive procedures, doctors, using the Stethotron Cerebral Stethoscope, can now quickly and easily detect the atherosclerotic changes leading to cerebral aneurysms before acute symptoms appear, when it may be too late and is costly to treat.
Please visit us on the web at http://www.stethotron.com to sample audible detection with the Stethotron.
About the Stethotron
Unlike ultrasound, the Stethotron is non-invasive and avoids listening to undesirable wavelengths. Using our patented filtration, doctors may detect the audible, vascular turbulence at 250-1000 Hz that reveals pathology. Eliminating the cost of ultrasound, and in only minutes, the Stethotron provides a revolution in doctor/patient care.
Source: ProTron Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.